myBiometry empowers patients with biological data to predict and prevent asthma attacks, using patented sensors and devices to measure airway inflammation and gather risk factors for asthma management.

myBiometry

myBiometry | 795 followers on LinkedIn. Biomarkers + Data Science &#61; Healthcare Reimagined | myBiometry is a platform to remotely monitor and manage patients with chronic conditions using software and biomarker data generated from proprietary sensors. Our initial focus is asthma.

VP, Digital Strategy - Fresenius Medical Care; Angel Investor

John Tremblay

Dad X2, Technology Executive, Investor and 2X Founder

Anmol Wassan

CoFounder Chemical Angel Network

Mark Vreeke

C-Suite Executive | Value and Growth Driver | Benefits & Technology

Sharon Cunninghis

myBiometry is developing a breath test and digital solution to monitor airway inflammation in asthma and COPD patients. The data helps identify risk of attack up to 20 days before symptoms. If you would like to support how we are transforming the lives of patients and caregivers for Asthma and COPD, please consider: - Watch our 1-minute video and hit LIKE on YouTube 👍 - Share it with your connections to spread the word! 👪 - Get in touch with us to help with our mission to prevent asthma attacks 🤙 We are thrilled to be included in the 2024 Cohort for MedTech Innovator accelerator. By watching our 1-minute video and liking us on YouTube you will also be supporting us to win MedTech Innovator Best Video. #asthma #copd #healthcareinnovation #endasthmaattacks Asthma and Allergy Foundation of America Global Initiative for Asthma American Medical Association American Lung Association American Thoracic Society AdvaMed MassChallenge UMassM2D2 MedTech Innovator

🌟 Exciting News: myBiometry’s Recent Fundraising Success! 🌟 We’re thrilled to announce that myBiometry has successfully completed our latest funding round! This support is a huge step forward in our mission to transform respiratory health management for asthma and COPD patients with predictive, at-home monitoring solutions. A big thank you to our investors and partners who believe in our vision and are helping us expand access to life-changing technology. We’re energized to drive the future of proactive healthcare! “We’re excited to partner with Dexcom 's Venture Group and CareSource as we near the milestone of submitting fenoTRACK for regulatory clearance,” said Bryan Nolan, CEO of myBiometry. “With enhanced at-home monitoring for asthma and COPD, we strive to identify attack risks sooner, enabling clinicians to offer more personalized care and preventive interventions that lessen the burden on patients, caregivers, and healthcare payers.” For more details, read our latest update here: mybiometry.com/news #HealthTech #Innovation #Fundraising #myBiometry #RespiratoryCare #Asthma #COPD

🌟 Honored to Be a Finalist for the 2024 MedTech Innovator Value Award! 🌟 We’re thrilled to announce that myBiometry has been selected as a finalist for the MedTech Innovator 2024 Value Award! This recognition celebrates healthcare solutions that demonstrate strong value to patients, providers, and payers by lowering costs, improving outcomes, and driving accessible innovation. Being recognized among such impactful companies is a tremendous honor, and we’re excited to continue our journey toward making a difference in patient care. The Award competitions will take place during the MedTech Strategist Innovation Summit in San Diego, with the Value Award Competition taking place on Tuesday, November 19, at 4:40 p.m. Thank you, MedTech Innovator , for this opportunity! #MedTechInnovator #ValueAward #Innovation #Healthcare #MedTech #medicaldevice #MTS24

🚀 Inspired by Innovation: Reflections from The MedTech Conference 2024 Last week at The MedTech Conference 2024 in Toronto, our team came away inspired by the incredible advancements shaping the future of healthcare. Our CEO, Bryan Nolan, had the honor of speaking on a panel about Breathing and Sleeping, where he shared insights on how predictive health technologies can empower patients with respiratory conditions. Hearing AdvaMed ’s CEO, Scott Whitaker , reflect on past innovations reminded us that the most transformative ideas often start as bold dreams. At myBiometry , we are committed to helping Asthma and COPD patients change the trajectory of their lives through proactive and predictive health data—and we hope our work will be among the breakthroughs Whitaker celebrates in the future. We were also inspired by the many remarkable advancements showcased in his keynote, such as: - From needles and blood draws to insulin pumps and continuous glucose monitors. - From open-heart surgeries to minimally invasive procedures. - Pacemakers shrinking from car batteries to nickel-sized devices. - Heart monitors evolving from bulky equipment to wearable patches that gather data over days. - And from people once told they would never walk again to now carrying the Olympic torch. The future of healthcare is here, and we are proud to be a part of this exciting journey, bringing innovative solutions to help patients breathe easier and live better. #MedTechCon #HealthcareInnovation #Asthma #COPD #PredictiveHealth #MedicalTechnology #myBiometry #Toronto #Inspiration #medtechinnovator

Next week, our CEO, Bryan Nolan will be presenting on the "Breathing and Sleeping" panel at the MedTech Conference in Toronto! 🎤 Bryan will be discussing the future of innovation in asthma and COPD diagnostics and management, sharing insights on how our company is driving advancements that are transforming patient care and the healthcare industry. Join us as we connect with fellow industry leaders and thought partners on this global stage. 🌍 📅 Date: October 15, 2024 @ 1:35PM 📍 Location: Toronto, MedTech Conference #MedTechCon #MTC24 #MTI #HealthcareInnovation #Leadership #Toronto #FutureOfHealthcare #Innovation #PanelSpeaker #asthma #COPD MedTech Innovator

September is peak asthma month - it's important to get your asthma under control. From our friends at Asthma and Allergy Foundation of America : 1. Schedule an appointment with your doctor or asthma specialist now. Be ready to talk about current symptoms, medicines, and triggers. If you have symptoms more than 2 times a week, your asthma isn’t under control. 2. Talk with your doctor about creating an Asthma Action Plan. It's a document to help you manage your asthma. It has medicine instructions and what to do when your asthma gets worse or if you are having an asthma emergency. 3. Get vaccinated. Flu and COVID-19 vaccines reduce the risk of severe illness and help keep you out of the hospital. These vaccines are updated every year. Talk with your doctor about which vaccines you and your family need and get them as soon as they are available. 4. Improve your indoor air quality. Indoor air can be much more polluted than outdoor air. Good ventilation and air cleaners and filters can improve your indoor air quality (IAQ). This content is developed independently by AAFA and made possible by support from Amgen. #endasthmaattacks

myBiometry is excited to announce that we are part of MedTech Innovator 2024. myBiometry shares MedTech Innovator 's vision to improve the lives of patients by transforming the healthcare system. MedTech Innovator is the premier accelerator for medical device, digital health, and diagnostic companies accepting 5% of applicants. Congratulations to our cohort companies and thank you to the sponsors. For more details: https://lnkd.in/eq8zbHmR #medtech #endasthmaattacks #copd #asthma #medicaldevice #digitalhealth #mti #healthinnovation #IAmAnInnovator

The ATS International Conference 2024 is the premier conference for pulmonary, critical care, and sleep professionals from around the world to explore groundbreaking research, the latest clinical developments, and cutting-edge science. myBiometry will be presenting its patented asthma management solution at the 2024 Respiratory Innovation Summit preceding the conference featured at the "Technology Innovators: Devices, Digital, AI" showcase. We would love to meet physicians, patients and partners who share our mission to serve asthma and COPD patients and families through a personalized, and proactive approach to prevent asthma attacks. #asthma #healthcareinnovation #ATS2024 Bryan Nolan Anmol Wassan

myBiometry is thrilled to be selected as a Showcase Company at the American Thoracic Society 's 2024 Respiratory Innovation Summit. Our CEO, Bryan Nolan will be presenting on how our technology can help transform asthma care by empowering patients and physicians with better data. Please get in touch if you would like to connect to learn more. #asthma #healthinnovation #endasthmaattacks #ats2024

MYBI

COM:MYBIOMETRY

myBiometry

locale

market

industry

website

crunchbase

linkedin

investor of

Metrics